In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kipchu Tshering, Mir Misbahuddin
Formato: Artigo
Lenguaje:Inglês
Publicado: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Colección:Bangabandhu Sheikh Mujib Medical University Journal
Materias:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Acceso en línea:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares